{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Lifestance Health Group, Inc.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of October 31, 2025, Lifestance Health Group, Inc. is in a bearish trend with weak strength indicators, having underperformed the S&P 500 significantly with a year-to-date return of -32.43% compared to the index's 16.30%.
Lifestance Health Group, Inc. Experiences Revision in Stock Evaluation Amid Market Fluctuations
Lifestance Health Group, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock has shown mixed technical indicators, with varying trends in momentum. Year-to-date, it has significantly underperformed compared to the S&P 500, reflecting challenges in maintaining competitiveness in the pharmaceuticals and biotechnology sector.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of October 31, 2025, Lifestance Health Group, Inc. is in a bearish trend with weak strength, underperforming the S&P 500 significantly, showing a year-to-date return of -33.24% compared to the S&P 500's 16.30%.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of October 31, 2025, Lifestance Health Group, Inc. is in a bearish trend with weak strength indicators, having underperformed the S&P 500 significantly with a year-to-date return of -33.51%.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of October 31, 2025, Lifestance Health Group, Inc. is in a bearish trend with weak strength, indicated by daily moving averages and bearish signals from Bollinger Bands and monthly MACD, while underperforming the S&P 500 with a year-to-date return of -33.51%.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of August 13, 2025, Lifestance Health Group, Inc. shows a mildly bearish trend, with mixed signals from moving averages and indicators, and a year-to-date return of -27.14% compared to the S&P 500's 12.22%.
Is Lifestance Health Group, Inc. overvalued or undervalued?
As of November 8, 2021, Lifestance Health Group, Inc. is considered a risky investment due to its overvaluation, negative P/E ratio, poor returns on capital, and significant underperformance compared to the S&P 500.
Is Lifestance Health Group, Inc. overvalued or undervalued?
As of November 8, 2021, Lifestance Health Group, Inc. is rated as "risky" and overvalued, with a Price to Book Value of 1.56, an EV to EBITDA of 49.80, a negative ROE of -2.24%, and a year-to-date stock return of -32.7%, significantly underperforming the S&P 500's 2.44%.
Is Lifestance Health Group, Inc. technically bullish or bearish?
As of June 13, 2025, Lifestance Health Group, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD readings, moving averages, and a significant underperformance of -32.7% year-to-date compared to the S&P 500's 2.44%.
What does Lifestance Health Group, Inc. do?
Lifestance Health Group, Inc. is a small-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $333 million and a net profit of $1 million as of March 2025. Key metrics include a market cap of $1.96 billion, a debt-to-equity ratio of 0.14, and a return on equity of -2.24%.
How big is Lifestance Health Group, Inc.?
As of Jun 18, Lifestance Health Group, Inc. has a market capitalization of 1,959.93 million and reported net sales of 1,283.50 million with a net profit of -35.64 million. Shareholder's funds were 1,446.29 million, and total assets were 2,227.04 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
